Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
CREATE MEDIC, 39% Increase in Ordinary Profit for The Current Fiscal Year
5187 CREATE MEDIC CO.,LTD. 【J-GAAP】
Earnings ReportCREATE MEDIC CO.,LTD. <5187> [TSE Std] announced its financial results after the market closed on February 13th (15:30). The consolidated ordinary profit for the fiscal year ending December 2024 decreased 14.0% from the previous period to 0.75 billion yen. In the fiscal year ending December 2025, the profit is expected to expand to 39.1% to 1.04 billion yen. This will be the fifth consecutive term of revenue growth.
At the same time, the company plans to remove the commemorative dividend of the previous term and set the dividend for this term at an ordinary dividend of 37 yen.
In the most recent three-month period, from October to December (4Q), the consolidated ordinary profit decreased to 0.2 billion yen, a 7.2% decrease compared to the same period last year. The operating profit margin worsened from 5.6% in the same period last year to 4.9%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2022 | 12,326 | 741 | 834 | 482 | 53.0 | 37 | Feb 13, 2023 | J-GAAP |
Dec, 2023 | 12,585 | 803 | 872 | 154 | 16.9 | 37 | Feb 14, 2024 | J-GAAP |
Dec, 2024 | 13,030 | 692 | 750 | 840 | 95.4 | 39 | Feb 13, 2025 | J-GAAP |
YoY | +3.5% | -13.8% | -14.0% | +445.5% | +463.9% |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2024 Guidance | 13,032 | 868 | 900 | 967 | 112.6 | 39 | Feb 14, 2024 | J-GAAP |
Dec, 2024 Results | 13,030 | 692 | 750 | 840 | 95.4 | 39 | Feb 13, 2025 | J-GAAP |
Revision Rate | 0.0% | -20.3% | -16.7% | -13.1% | -15.3% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Jun, 2024 | 6,300 | 291 | 345 | 550 | 61.4 | 19 | Aug 5, 2024 | J-GAAP |
Jan - Jun, 2025 Guidance | 6,397 | 309 | 352 | 192 | 22.6 | 17 | Feb 13, 2025 | J-GAAP |
YoY | +1.5% | +6.2% | +2.0% | -65.1% | -63.1% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2023 | 12,585 | 803 | 872 | 154 | 16.9 | 37 | Feb 14, 2024 | J-GAAP |
Dec, 2024 | 13,030 | 692 | 750 | 840 | 95.4 | 39 | Feb 13, 2025 | J-GAAP |
Dec, 2025 Guidance | 13,583 | 1,002 | 1,043 | 796 | 94.0 | 37 | Feb 13, 2025 | J-GAAP |
YoY | +4.2% | +44.8% | +39.1% | -5.2% | -1.5% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 3,417 | 191 | 221 | 145 | 15.9 | 5.6 | Feb 14, 2024 | J-GAAP |
Jan - Mar, 2024 | 2,976 | 98 | 106 | 59 | 6.5 | 3.3 | May 7, 2024 | J-GAAP |
Apr - Jun, 2024 | 3,324 | 193 | 239 | 491 | 54.8 | 5.8 | Aug 5, 2024 | J-GAAP |
Jul - Sep, 2024 | 3,212 | 230 | 200 | 194 | 21.9 | 7.2 | Oct 31, 2024 | J-GAAP |
Oct - Dec, 2024 | 3,518 | 171 | 205 | 96 | 10.9 | 4.9 | Feb 13, 2025 | J-GAAP |
YoY | +3.0% | -10.5% | -7.2% | -33.8% | -31.6% |
Related Articles
YKT, 89% Increase in Ordinary Profit for The Current Fiscal Year
Jibannet, The Current Fiscal Year Ordinary Profit Revised Upward by 2.2 times
Tokushu Tokai Paper, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 2%
TEAR Corp, Oct-Dec (1Q) Ordinary Profit Increases by 2.4 times
Kumagai Gumi, The Current Fiscal Year Ordinary Profit Revised Downward to an Unexpected 8% Decrease
Disruptors, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 5.6 times, Oct-Dec Ordinary Profit Turns to Profit
TAIKO PHARMA, 71% Decrease in Ordinary Profit for The Current Fiscal Year
Vertex, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 9%
IFIS JAPAN, 14% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen
Nippon Soda, Oct-Dec (3Q) Ordinary Profit Increases by 3%